SEARCH

SEARCH BY CITATION

References

  • Abramov A. Y. and Duchen M. R. (2005) The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides. Philos. Trans. R. Soc. Lond. B Biol. Sci. 360, 23092314.
  • Anfuso C. D., Assero G., Lupo G., Nicotra A., Cannavo G., Strosznajder R. P., Rapisarda P., Pluta R. and Alberghina M. (2004) Amyloid beta(1-42) and its beta(25-35) fragment induce activation and membrane translocation of cytosolic phospholipase A2 in bovine retina capillary pericytes. Biochim. Biophys. Acta 1686, 125138.
  • Ban J. Y., Jeon S. Y., Bae K., Song K. S. and Seong Y. H. (2006) Catechin and epicatechin from Smilacis chinae rhizome protect cultured rat cortical neurons against amyloid beta protein (25-35)-induced neurotoxicity through inhibition of cytosolic calcium elevation. Life Sci. 79, 22512259.
  • Bazan N. G., Packard M. G., Teather L. and Allan G. (1997) Bioactive lipids in excitatory neurotransmission and neuronal plasticity. Neurochem. Int. 30, 225231.
  • Bedard K. and Krause K. H. (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87, 245313.
  • Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248254.
  • Butterfield D. A. and Pocernich C. B. (2003) The glutamatergic system and Alzheimer’s disease: therapeutic implications. CNS Drugs 17, 641652.
  • Chalimoniuk M., Stolecka A., Cakala M. et al. (2007) Amyloid beta enhances cytosolic phospholipase A(2) level and arachidonic acid release via nitric oxide in APP-transfected PC12 cells. Acta Biochim. Pol. 54, 611623.
  • Chapman K. E., Sinclair S. E., Zhuang D., Hassid A., Desai L. P. and Waters C. M. (2005) Cyclic mechanical strain increases reactive oxygen species production in pulmonary epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 289, L834L841.
  • Choi D. W. (1992) Excitotoxic cell death. J. Neurobiol. 23, 12611276.
  • Coffer P. J., Geijsen N., M’Rabet L., Schweizer R. C., Maikoe T., Raaijmakers J. A., Lammers J. W. and Koenderman L.(1998) Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function. Biochem. J. 329(Pt. 1), 121130.
  • Dahlgren K. N., Manelli A. M., Stine W. B. Jr, Baker L. K., Krafft G. A. and LaDu M. J. (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277, 3204632053.
  • De Felice F. G., Velasco P. T., Lambert M. P., Viola K., Fernandez S. J., Ferreira S. T. and Klein W. L. (2007) Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J. Biol. Chem. 282, 1159011601.
  • Drapeau C., Pellerin L., Wolfe L. S. and Avoli M. (1990) Long-term changes of synaptic transmission induced by arachidonic acid in the CA1 subfield of the rat hippocampus. Neurosci. Lett. 115, 286292.
  • Dringen R. (2005) Oxidative and antioxidative potential of brain microglial cells. Antioxid. Redox Signal. 7, 12231233.
  • Dumuis A., Sebben M., Haynes L., Pin J. P. and Bockaert J. (1988) NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 336, 6870.
  • Farooqui A. A., Ong W. Y. and Horrocks L. A. (2006) Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol. Rev. 58, 591620.
  • Geijsen N., Dijkers P. F., Lammers J. J., Koenderman L. and Coffer P. J. (2000) Cytokine-mediated cPLA(2) phosphorylation is regulated by multiple MAPK family members. FEBS Lett. 471, 8388.
  • Harkany T., Hortobagyi T., Sasvari M., Konya C., Penke B., Luiten P. G. and Nyakas C. (1999) Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer’s disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 23, 9631008.
  • Infanger D. W., Sharma R. V. and Davisson R. L. (2006) NADPH oxidases of the brain: distribution, regulation, and function. Antioxid. Redox Signal. 8, 15831596.
  • Kelly B. L. and Ferreira A. (2006) beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons. J. Biol. Chem. 281, 2807928089.
  • Kishida K. T. and Klann E. (2007a) Sources and targets of reactive oxygen species in synaptic plasticity and memory. Antioxid. Redox Signal. 9, 233244.
  • Kishida K. T. and Klann E. (2007b) Sources and targets of reactive oxygen species in synaptic plasticity and memory. Antioxid. Redox Signal. 9, 233244.
  • Kishida K. T., Pao M., Holland S. M. and Klann E. (2005) NADPH oxidase is required for NMDA receptor-dependent activation of ERK in hippocampal area CA1. J. Neurochem. 94, 299306.
  • Kriem B., Sponne I., Fifre A. et al. (2005) Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide. FASEB J. 19, 8587.
  • Lee B. Y., Ban J. Y. and Seong Y. H. (2005) Chronic stimulation of GABAA receptor with muscimol reduces amyloid beta protein (25-35)-induced neurotoxicity in cultured rat cortical cells. Neurosci. Res. 52, 347356.
  • Lin L. L., Wartmann M., Lin A. Y., Knopf J. L., Seth A. and Davis R. J. (1993) cPLA2 is phosphorylated and activated by MAP kinase. Cell 72, 269278.
  • Mattson M. P., Barger S. W., Begley J. G. and Mark R. J. (1995) Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46, 187216.
  • McKeel D. W. Jr, Price J. L., Miller J. P., Grant E. A., Xiong C., Berg L. and Morris J. C. (2004) Neuropathologic criteria for diagnosing Alzheimer disease in persons with pure dementia of Alzheimer type. J. Neuropathol. Exp. Neurol. 63, 10281037.
  • Medina J. H. and Izquierdo I. (1995) Retrograde messengers, long-term potentiation and memory. Brain Res. Brain Res. Rev. 21, 185194.
  • Mendes C. T., Gattaz W. F., Schaeffer E. L. and Forlenza O. V. (2005) Modulation of phospholipase A2 activity in primary cultures of rat cortical neurons. J. Neural Transm. 112, 12971308.
  • Nicotra A., Lupo G., Giurdanella G., Anfuso C. D., Ragusa N., Tirolo C., Marchetti B. and Alberghina M. (2005) MAPKs mediate the activation of cytosolic phospholipase A2 by amyloid beta(25-35) peptide in bovine retina pericytes. Biochim. Biophys. Acta 1733, 172186.
  • Nishizaki T., Nomura T., Matsuoka T., Enikolopov G. and Sumikawa K. (1999) Arachidonic acid induces a long-lasting facilitation of hippocampal synaptic transmission by modulating PKC activity and nicotinic ACh receptors. Brain Res. Mol. Brain Res. 69, 263272.
  • Noh K. M. and Koh J. Y. (2000) Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J. Neurosci. 20, RC111.
  • Nunomura A., Perry G., Aliev G. et al. (2001) Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 759767.
  • Oomagari K., Buisson B., Dumuis A., Bockaert J. and Pin J. P. (1991) Effect of glutamate and ionomycin on the release of arachidonic acid, prostaglandins and HETEs from cultured neurons and astrocytes. Eur. J. Neurosci. 3, 928939.
  • Parks J. K., Smith T. S., Trimmer P. A., Bennett J. P. Jr and Parker W. D. Jr (2001) Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro. J. Neurochem. 76, 10501056.
  • Parsons C. G., Stoffler A. and Danysz W. (2007) Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system – too little activation is bad, too much is even worse. Neuropharmacology 53, 699723.
  • Qin L., Liu Y., Cooper C., Liu B., Wilson B. and Hong J. S. (2002) Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J. Neurochem. 83, 973983.
  • Qiongman Kong M. W., Zhongji Liao., Jean M. Camden., Sue Yu., Agnes Simonyi., Grace Y. Sun., Fernando A., Gonzalez L. E., Cheikh I. Seye. and Gary A. Weisman. (2005) P2X7 nucleotide receptors mediate caspase-8/9/3-dependent apoptosis in rat primary cortical neurons. Purinergic Signal. 1, 337347.
  • Rao J. S., Ertley R. N., Rapoport S. I., Bazinet R. P. and Lee H. J. (2007) Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2. J. Neurochem. 102, 19181927.
  • Rey F. E., Cifuentes M. E., Kiarash A., Quinn M. T. and Pagano P. J. (2001) Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ. Res. 89, 408414.
  • Rowan M. J., Klyubin I., Wang Q. and Anwyl R. (2004) Mechanisms of the inhibitory effects of amyloid beta-protein on synaptic plasticity. Exp. Gerontol. 39, 16611667.
  • Samanta S., Perkinton M. S., Morgan M. and Williams R. J. (1998) Hydrogen peroxide enhances signal-responsive arachidonic acid release from neurons: role of mitogen-activated protein kinase. J. Neurochem. 70, 20822090.
  • Sanfeliu C., Hunt A. and Patel A. J. (1990) Exposure to N-methyl-D-aspartate increases release of arachidonic acid in primary cultures of rat hippocampal neurons and not in astrocytes. Brain Res. 526, 241248.
  • Selkoe D. J. (2002) Alzheimer’s disease is a synaptic failure. Science 298, 789791.
  • Small D. H., Mok S. S. and Bornstein J. C. (2001) Alzheimer’s disease and Abeta toxicity: from top to bottom. Nat. Rev. Neurosci. 2, 595598.
  • Snyder E. M., Nong Y., Almeida C. G. et al. (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8, 10511058.
  • Sun G. Y., Xu J., Jensen M. D. and Simonyi A. (2004) Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J. Lipid Res. 45, 205213.
  • Sun G. Y., Horrocks L. A. and Farooqui A. A. (2007) The roles of NADPH oxidase and phospholipases A(2) in oxidative and inflammatory responses in neurodegenerative diseases. J. Neurochem. 103, 116.
  • Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A. and Katzman R. (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572580.
  • Townsend M., Mehta T. and Selkoe D. J. (2007) Soluble abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J. Biol. Chem. 282, 3330533312.
  • Xu J., Weng Y. I., Simonyi A., Krugh B. W., Liao Z., Weisman G. A., Sun G. Y. and Simoni A. (2002) Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes. J. Neurochem. 83, 259270.
  • Xue D., Xu J., McGuire S. O., Devitre D. and Sun G. Y. (1999) Studies on the cytosolic phospholipase A2 in immortalized astrocytes (DITNC) revealed new properties of the calcium ionophore, A23187. Neurochem. Res. 24, 12851291.
  • Yatin S. M., Varadarajan S., Link C. D. and Butterfield D. A.(1999) In vitro and in vivo oxidative stress associated with Alzheimer’s amyloid beta-peptide (1-42). Neurobiol. Aging 20, 325330; discussion 339–342.
  • Zekry D., Epperson T. K. and Krause K. H. (2003) A role for NOX NADPH oxidases in Alzheimer’s disease and other types of dementia? IUBMB Life 55, 307313.
  • Zhu D., Lai Y., Shelat P. B., Hu C., Sun G. Y. and Lee J. C. (2006) Phospholipases A2 mediate amyloid-beta peptide-induced mitochondrial dysfunction. J. Neurosci. 26, 1111111119.
  • Zoladz P. R., Campbell A. M., Park C. R., Schaefer D., Danysz W. and Diamond D. M. (2006) Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane. Pharmacol. Biochem. Behav. 85, 298306.